Pharmaceutical Editorial
  • Home
  • News
  • About
  • Contact

Rite Aid Readies for 2015 Medicare Part D Enrollment

Pharmacy, Press Releases

Rite Aid Offering Resources In-Store and Online to Help Customers Choose the Best Prescription Drug Plan for 2015

Camp Hill, Pa. (Oct. 14, 2014) – To help senior customers as they get ready to select a prescription drug plan (PDP) or update their existing coverage during the upcoming annual Medicare Part D enrollment period, Rite Aid is once again offering free resources. Beginning Oct. 15, customers can use Rite Aid’s Medicare Advisor, available at any Rite Aid pharmacy, to request the three lowest-cost prescription drug plans based on current prescriptions filled at Rite Aid*. Rite Aid’s Medicare Advisor is also available online at www.riteaid.com/medicareadvisor.

“Rite Aid is committed to offering convenient, informative and easy-to-understand resources to help our customers make the best decisions to achieve their individual health and wellness goals,” said Robert I. Thompson, executive vice president of pharmacy for Rite Aid. “Prescriptions play an important role in maintaining good health and that’s why it’s important to review your prescription drug coverage each year. Accessible in Rite Aid pharmacies nationwide or from home, our Medicare Advisor is a valuable tool for customers evaluating their prescription coverage, helping them to confidently choose the best plan based on their prescription needs.”

With Rite Aid’s Medicare Advisor, customers can compare the estimated annual costs of various plans, including monthly premiums, brand and generic co-pays and drugs covered. Customers can then discuss their Medicare Advisor report with their Rite Aid pharmacists, who are available to answer questions they may have.

Rite Aid will serve as the exclusive co-branded preferred pharmacy provider for the new Symphonix Rite Aid Premier Rx (PDP)**. There is no deductible for those enrolled in the plan, which also offers low copays and covers an expansive list of covered medications. Rite Aid is also the exclusive preferred pharmacy provider for the Symphonix Rite Aid Value Rx (PDP)**. Both plans are available everywhere Rite Aid operates except Connecticut, Massachusetts, New York, Pennsylvania, Rhode Island, Virginia and West Virginia.

Rite Aid is in the networks of hundreds of other Medicare prescription drug plans; see www.riteaid.com/medicareadvisor for more information.

The Medicare Part D enrollment period runs through December 7, 2014.

Rite Aid Corporation (NYSE: RAD) is one of the nation’s leading drugstore chains with nearly 4,600 stores in 31 states and the District of Columbia and fiscal 2014 annual revenues of $25.5 billion. Information about Rite Aid, including corporate background and press releases, is available through the company’s website at www.riteaid.com.

###

*A complete list of all the Part D plans Rite Aid participates in is also available upon request. **Other pharmacies are available in the network. Rite Aid participates with other Medicare Part D Plans. A full list of all Prescription Drug Plans with which Rite Aid participates is available upon request. Symphonix Rite Aid Premier Rx and Symphonix Rite Aid Value Rx are offered by Symphonix Health Insurance, a Part D Plan with a Medicare Contract. Enrollment in Symphonix Rite Aid Value Rx and Symphonix Rite Aid Premier Rx depends on contract renewal. The benefit information provided is a summary, not a complete description of benefits. Limitations, copayments and restrictions may apply. Benefits, pharmacy network and/or copayments/co-insurance may change on January 1 of each year. You must continue to pay your Part B premiums.

SOURCE: Rite Aid

Related Posts

Medical, Pharmaceutical, Pharmaceuticals, Press Releases

Flexion to Present New Cost-Effectiveness Data on Zilretta™ (FX006) at the International Society for Pharmacoeconomics and Outcomes Research 22nd International Meeting

Allergan, Medical, Pharmaceutical, Pharmaceuticals, Press Releases

Allergan’s Eyepowerment™ Campaign Releases Survey Revealing the Importance of Eye Language and the Crucial Role it Plays in Our Communications

Medical, Pharmaceutical, Pharmaceuticals, Press Releases

The Centers for Disease Control and Prevention Updated Guideline Now Include a Recommendation for Triclosan-Coated Sutures

Featured News

  • Flexion to Present New Cost-Effectiveness Data on Zilretta™ (FX006) at the International Society for Pharmacoeconomics and Outcomes Research 22nd International Meeting
  • Allergan’s Eyepowerment™ Campaign Releases Survey Revealing the Importance of Eye Language and the Crucial Role it Plays in Our Communications
  • The Centers for Disease Control and Prevention Updated Guideline Now Include a Recommendation for Triclosan-Coated Sutures
  • Abbott Announces CE Mark for Tacticath™ Contact Force Ablation Catheter, Sensor Enabled™
  • Abbott Announces CE Mark and First Use of the World’s First SmartPhone Compatible Insertable Cardiac Monitor
Pharmaceutical Editorial
Copyright © PhysicianEditorial.com
All Rights Reserved!